Is it acceptable to approach colorectal cancer patients at diagnosis to discuss genetic testing? A pilot study

M Porteous, M Dunckley, S Appleton, S Catt, M Dunlop, H Campbell, A Cull

Research output: Contribution to journalArticlepeer-review

Abstract / Description of output

In this pilot study, the acceptability of approaching 111 newly diagnosed colorectal cancer patients with the offer of genetic testing for hereditary nonpolyposis colorectal cancer (HNPCC) was assessed. A total of 78% of participants found it highly acceptable to have the information about HNPCC brought to their attention at that time.
Original languageEnglish
Pages (from-to)1400-1402
JournalBritish Journal of Cancer
Volume89
Issue number8
DOIs
Publication statusPublished - 20 Oct 2003

Fingerprint

Dive into the research topics of 'Is it acceptable to approach colorectal cancer patients at diagnosis to discuss genetic testing? A pilot study'. Together they form a unique fingerprint.

Cite this